Close

Analyst Ratings for Corcept Therapeutics (CORT)

CORT Rating Summary

CORT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CORT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $36.00 (+35.2%) * Over Last 12-Mos
Rating Score: 5.3 / 10   Percentile Rank: 54%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/1/2022 Truist Securities Gregory Fraser Downgrade Hold
(Buy)
30.00
(N/A)
28.66
(26.62)
-7.12% Details
7/27/2022 Jefferies Dennis Ding New Coverage Buy
(N/A)
35.00
(N/A)
26.81
(26.62)
-0.71% Details
Like CORT Ratings? Also take a look at MFIN, AGFY, RBB, CDNA

CORT Ratings News